Comerica Bank’s vTv Therapeutics VTVT Stock Holding History

Comerica Bank’s Portfolio VTVT Stock Details VTVT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-25	Closed	-$478	–	3836
2023 Q3	$478	Buy	+25	New	+$611	﹤0.01%	3718

Other funds holding VTVT

Samsara BioCapital Palo Alto, California $1.03B AUM 214.94% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

TRCT

Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

FWM

Focused Wealth Management Newburgh, New York $964M AUM 18.71% 1-Year Est. Return

Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

Parallel Advisors San Francisco, California $5.56B AUM 17.89% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Comerica Bank's VTVT Position: Q4 2023 in Review

Comerica Bank sold out of vTv Therapeutics (VTVT) in Q4 2023, closing a stake of 25 shares — an estimated $478 sold.

Comerica Bank first reported a position in VTVT in Q3 2023 and held it in 1 quarter. The position peaked at $478 in Q3 2023. 14 funds tracked by Wall St. Rank hold VTVT as of Q4 2023.

Comerica Bank reported no remaining vTv Therapeutics position as of Q4 2023 after selling out during the quarter.
Comerica Bank sold 25 vTv Therapeutics shares in Q4 2023, an estimated $478.
Comerica Bank first reported a position in vTv Therapeutics in Q3 2023 and held it in 1 quarter.
Comerica Bank's vTv Therapeutics position peaked at $478 in Q3 2023.
14 funds tracked by Wall St. Rank held vTv Therapeutics as of Q4 2023.

Based on Comerica Bank's 13F filing for Q4 2023, filed 14 Feb 2024.